The global intracranial hemorrhage devices market is expected to surge due to the rising cases of brain disorders such as stroke, cerebral/brain aneurysm, the growing burden of the elderly population suffering from brain disorders, shifting focus towards the development of technologically advanced ICH devices, and others.
New York, USA, Jan. 05, 2023 (GLOBE NEWSWIRE) — The Global Intracranial Hemorrhage Devices Market to Exhibit Growth at a CAGR of 6.65% by 2027 | DelveInsight
The global intracranial hemorrhage devices market is expected to surge due to the rising cases of brain disorders such as stroke, cerebral/brain aneurysm, the growing burden of the elderly population suffering from brain disorders, shifting focus towards the development of technologically advanced ICH devices, and others.
DelveInsight’s Intracranial Hemorrhage Devices Market Insights report provides the current and forecast market analysis, individual leading intracranial hemorrhage devices companies’ market shares, challenges, intracranial hemorrhage devices market drivers, barriers, and trends, and key intracranial hemorrhage devices companies in the market.
Key Takeaways from the Intracranial Hemorrhage Devices Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global intracranial hemorrhage devices market during the forecast period.
- Notable intracranial hemorrhage devices companies such as ClearMind Biomedical Inc., Medtronic, Stryker, InfraScan, Inc., MicroPort Scientific Corporation, Penumbra, Inc., Acandis GmbH, Cerenovus (Johnson & Johnson Services, Inc.), MicroVention Inc. (Terumo Corporation), Invamed, B. Braun Melsungen AG, adeor medical AG, SCHINDLER Endoskopie Technologie, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, Kaneka Medix Corporation, Hyperfine, General Electric Company, phenox GmbH, Perflow Medical Ltd., and several others are currently operating in the intracranial hemorrhage devices market.
- In August 2022, BrainScope Company Inc. announced that Vizient, Inc., the nation’s largest member-driven healthcare performance improvement company, has awarded an Innovative Technology contract to its FDA-cleared, handheld, Class 2 medical device that uses artificial intelligence and machine learning technology to identify objective biomarkers of structural (intracranial hemorrhage) and functional (concussion) brain injury in patients with suspected mild traumatic brain injury (mTBI).
- In February 2022, the FDA granted expanded indication to Infrascanner, a handheld device used for detecting traumatic supratentorial hematomas in adults, to include pediatric patients aged 2 years and older.
- In November 2021, FUJIFILM Healthcare Americas Corporation’s REiLI® Artificial Intelligence Platform was used for clinical purposes for intracranial hemorrhage.
To read more about the latest highlights related to the intracranial hemorrhage devices market, get a snapshot of the key highlights entailed in the Global Intracranial Hemorrhage Devices Market Report
Intracranial Hemorrhage Devices Overview
An intracranial hemorrhage is bleeding inside the skull (cranium) that can be fatal. Intracerebral hemorrhage is one of the most common causes of stroke, accounting for approximately 15-30% of all strokes. Epidural hemorrhage, subdural hemorrhage, subarachnoid hemorrhage, and intraparenchymal hemorrhage are the most common types of intracranial hemorrhage. ICH devices are medical devices that are used to diagnose and treat the condition.
Intracerebral Hemorrhage treatment has grown tremendously in recent years and is expected to continue to evolve in the coming years due to companies’ active participation in the treatment landscape. Prompt medical treatment can help limit brain damage, increasing your chances of recovery. Surgery may be required in the following circumstances: Bleeding (hemorrhage) may necessitate immediate brain decompression to release pooled blood and relieve pressure.
Intracranial Hemorrhage Devices Market Insights
North America is expected to account for the largest share of the global intracranial hemorrhage devices market out of all regions. Rising cases of brain disorders such as stroke and cerebral/brain aneurysm, as well as rising incidences of intracranial hemorrhage, are expected to aid in the growth of the North American intracranial hemorrhage devices market.
Furthermore, rising product approvals and new technologies, such as the incorporation of AI in these devices in the country, will drive the intracranial hemorrhage devices market growth. For example, in November 2021, FUJIFILM Healthcare Americas Corporation’s REiLI® Artificial Intelligence Platform was used for clinical purposes for intracranial hemorrhage. As a result, the interaction of various factors, such as the presence of a large patient population, encouraging reimbursement policies, and new product launches in the region, is expected to boost the North American intracranial hemorrhage devices market during the forecast period.
To know more about why North America is leading the market growth in the intracranial hemorrhage devices market, get a snapshot of the Intracranial Hemorrhage Devices Market Outlook
Intracranial Hemorrhage Devices Market Dynamics
The intracranial hemorrhage devices market is experiencing increased product demand for a variety of reasons. The rising burden of patients suffering from brain disorders such as stroke, cerebral/brain aneurysm, intracranial stenosis, and others around the world is expected to fuel demand for intracranial hemorrhage devices, as these devices are used to treat various conditions and diseases of the brain using minimally invasive neurosurgical techniques.
However, the risks associated with intracranial hemorrhage devices and the high cost of equipment and surgeries may be some of the intracranial hemorrhage devices market limiting factors.
Additionally, the COVID-19 outbreak impacted the use of intracranial hemorrhage devices in the market. Intracerebral hemorrhage is a very rare but well-documented COVID-19 complication. Stroke has been identified as a COVID-19 manifestation, with 0.9% to 23% of COVID-19 patients developing brain stroke. COVID-19 patients have a prothrombotic state, which means their blood tends to thicken or become sticky, clogging the blood vessels supplying the brain; the blood supply to a specific part of the brain is cut off, resulting in stroke symptoms. This increased the demand for intracranial hemorrhage devices.
Get a sneak peek at the intracranial hemorrhage devices market dynamics @ Intracranial Hemorrhage Devices Market Dynamics Analysis
| Report Metrics | Details |
| Coverage | Global |
| Study Period | 2019–2027 |
| Base Year | 2021 |
| Intracranial Hemorrhage Devices Market CAGR | 6.65% |
| Projected Intracranial Hemorrhage Devices Market Size by 2027 | USD 2.35 Billion |
| Key Intracranial Hemorrhage Devices Companies | ClearMind Biomedical Inc., Medtronic, Stryker, InfraScan, Inc., MicroPort Scientific Corporation, Penumbra, Inc., Acandis GmbH, Cerenovus (Johnson & Johnson Services, Inc.), MicroVention Inc. (Terumo Corporation), Invamed, B. Braun Melsungen AG, adeor medical AG, SCHINDLER Endoskopie Technologie, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, Kaneka Medix Corporation, Hyperfine, General Electric Company, phenox GmbH, Perflow Medical Ltd., among others |
Intracranial Hemorrhage Devices Market Assessment
- Intracranial Hemorrhage Devices Market Segmentation
- Market Segmentation By Product Type: Diagnosis (Neuroendoscopes, CT, MRI, Others), Treatment (Embolization Devices, Intracranial Stents, Balloon Occlusion Devices, Neurothrombectomy Devices, Others)
- Market Segmentation By End User: Hospitals, Ambulatory Surgical Centers, Others
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the intracranial hemorrhage devices market are set to emerge as the trendsetter explore @ Intracranial Hemorrhage Devices Companies
Table of Contents
| 1 | Report Introduction |
| 2 | Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Intracranial Hemorrhage Devices Market |
| 7 | Intracranial Hemorrhage Devices Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Intracranial Hemorrhage Devices Market Company and Product Profiles |
| 10 | Project Approach |
| 11 | About DelveInsight |
Interested in knowing the intracranial hemorrhage devices market by 2027? Click to get a snapshot of the Intracranial Hemorrhage Devices Market Trends
Related Reports
Brain Aneurysm Stents Market
Brain Aneurysm Stents Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key brain aneurysm stents companies, including Phenox GmbH, Peter LAZIC GmbH, adeor medical AG., Boston Scientific Corporation, among others.
Peripheral Aneurysms Market
Peripheral Aneurysm Market Insights, Competitive Landscape and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key peripheral aneurysms companies, including Medtronic, Abbott, Stryker, among others.
Aortic Aneurysm Stent Grafts Market
Aortic Aneurysm Stent Grafts Market Insights, Competitive Landscape and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key aortic aneurysm stent grafts companies, including Medtronic, Terumo, Shanghai MicroPort Endovascular MedTech, among others.
Abdominal Aortic Aneurysm Market
Abdominal Aortic Aneurysm Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key abdominal aortic aneurysm companies, including Endologix LLC, Cardinal Health, Cook Medical, among others.
Aneurysmal Subarachnoid Hemorrhage Market
Aneurysmal Subarachnoid Hemorrhage Market Insights, Epidemiology and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key aneurysmal subarachnoid hemorrhage companies, including Idorsia Pharmaceuticals, BIT Pharma GmbH, Akari Therapeutics, among others.
Other Trending Reports
Chronic Pain Market | Amyotrophic Lateral Sclerosis Market | Glioblastoma Market | Postoperative Pain Market | Adeno-Associated Virus Vectors in Gene Therapy Market | Epilepsy Market | Parkinson’s Disease Market | Complex Regional Pain Syndrome Market | Drug-Induced Dyskinesia Market | Spasticity Market | Multiple System Atrophy (MSA) Market | Schizophrenia Market | Encephalitis Market | Opioid Use Disorder Market | Cerebral Aneurysm Market | Dementia Market
Related Healthcare Services
Healthcare Consulting
Healthcare Competitive Intelligence Services
Healthcare Asset Prioritization Services
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
CONTACT: Contact Us Shruti Thakur [email protected] +1(919)321-6187 https://www.delveinsight.com/medical-devices
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaChron.com takes no editorial responsibility for the same.